Smartleaf Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Smartleaf Asset Management’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.68K	Buy	+57	New	+$5.37K	﹤0.01%	2729

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Remedium Capital Partners Fort Lauderdale, Florida $274M AUM 288.41% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Smartleaf Asset Management's ORKA Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Oruka Therapeutics (ORKA) in Q3 2026: 57 shares worth $4.68K. The stake represents ﹤0.01% of the portfolio and ranks #2729 among its holdings.

175 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

Smartleaf Asset Management held 57 shares of Oruka Therapeutics worth $4.68K as of Q3 2026.
Oruka Therapeutics was a new Smartleaf Asset Management position in Q3 2026.
Oruka Therapeutics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2729 holding.
175 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.